Related Experiment Video
Updated: Jun 21, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Current options in the treatment of acute bronchospasm
1Department of pediatrics, division of allergy and immunology, College of Medicine, University of California, Irvine, USA. wberger@uci.edu
Abstract:
Asthma therapy has evolved significantly in the last 40 years from that used for primarily symptomatic relief to that which incorporates short-term relief agents, long-term preventive medications, and exacerbation relief products. Agents can now be prescribed for routine as well as emergency care. Continued development of medications are likely to offer patients better agents for control of their illness and mitigate occurrence of acute exacerbations. Better control allows for better patient health, reduced number of physician and emergency department visits, and reduced health care costs.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
COPD: Management Using Bronchodilators and Corticosteroids
